Since ECM expansion and mesangial proliferation are shown to be key components of glomerulosclerosis, STAT-3 inhibition was investigated for inhibition of glomerulosclerosis in many different kidney diseases such as diabetic or obstructive nephropathy in an animal model [40,41]. Here, STAT3 is linked to kidney disorder.